Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
Anniina Färkkilä(University of Helsinki), Panagiotis A. Konstantinopoulos(Dana-Farber Cancer Institute), Sandro Santagata(Harvard University), Connor A. Jacobson(Harvard University), Julia Casado(University of Helsinki), Peter J. Park(Harvard University), Zoltan Maliga(Harvard University), Sampsa Hautaniemi(University of Helsinki), Alan D. D’Andrea(Dana-Farber Cancer Institute), Geoffrey I. Shapiro(Brigham and Women's Hospital), Clarence Yapp(Harvard University), Ana Lako(Brigham and Women's Hospital), Ursula A. Matulonis(Dana-Farber Cancer Institute), Scott J. Rodig(Brigham and Women's Hospital), D. Gulhan(Harvard University), Peter K. Sorger(Harvard University Press), Yinghui Zhou(Soochow University), Elizabeth Garcia(Brigham and Women's Hospital), Denis Schapiro(Heidelberg University), Yu‐An Chen(Harvard University), Pamela N. Münster(University of California, San Francisco), Elizabeth M. Swisher(University of Washington), Bose Kochupurakkal(Brigham and Women's Hospital), Julie R. Graham(Tesaro (United States)), Dipanjan Chowdhury(Broad Institute), Bruce J. Dezube(Xilio Therapeutics (United States)), Huy Nguyen(Dana-Farber Cancer Institute)
Cited by 342
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
|Nature Methods|2014|2k